In a new study, researchers found that doctors are better at explaining the benefits of a common cancer screening that its potential downsides. But overtesting comes with risks and costs of its own.
States are battling the pharmaceutical industry in court to curb the opioid epidemic. NPR's Jennifer Ludden asks Richard Ausness, a law professor at the University of Kentucky, about the tactic.
Schools in the conservative country often have no sex ed, and it's a taboo topic at home. That's why Dr. Mahinder Watsa is one of the country's most popular advice columnists.
Officials in Texas are responding to the findings of an investigation by NPR and the Center for Public Integrity into drugmakers' influence over medication choices for Medicaid patients.
The announcement comes after health officials said an outbreak last month that sickened nearly 650 customers in Ohio was caused by a type of bacteria that thrives in food kept warm for long periods.
Medicare limits payments for minimally invasive replacement of aortic valves to hospitals with large numbers of heart procedures. But smaller facilities are crying foul.
The World Health Organization says violence and insecurity in the Democratic Republic of the Congo's North Kivu region is preventing health workers from stopping the spread of Ebola.
The FDA has approved a generic version of the EpiPen to treat dangerous allergic reactions, but it remains to be seen how much that will drive down the price of this expensive product.
New York University said the move was to address the high cost of entering a career in medicine. Most med students graduate in debt, which can often top $200,000.